New York City, NY, 27 September, 2018/24 Market Reports: This report studies the global Biodefense market status and forecast, categorizes the global Biodefense market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).
Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.
In the wake of the 2001 anthrax attacks, the U.S. government set out on a bold path to improve the country’s preparedness for bioterrorism by developing and stockpiling new drugs and vaccines to protect Americans from health emergencies. Since 2004, the US government has provided assistance in the development and manufacturing of products in order to maintain its Strategic National Stockpile (SNS) to counter any bioterror attack.
USA is still the largest supplier and consumption market due to the highly developed pharmaceuticals technology and increased awareness of the threat of global terror activity. In 2015, USA enjoyed over 80% consumption market.
By type, Anthrax defense products are most used with market share over 40%, followed by Smallpox defense products and Botulism defense products separately with market share about 30% and 14%. In addition, other diseases like Ebola and Marburg are occupying more and more market share.
In this year, the international situation is not complex, and partial conflict is frequent. Terrorist organization like IS was just making terrorist activity in Paris, which largely increased people’s awareness of the threat of terrorist activity. As a result, the biodefense industry is expecting in the next years.
The global Biodefense market is valued at 850 million US$ in 2017 and will reach 1500 million US$ by the end of 2025, growing at a CAGR of 7.3% during 2018-2025.
Biodefense Market Key Segment
Global Biodefense Market By manufacturers:
- Emergent Biosolutions
- Hytest
- GSK
- Sanofi
- PharmAthene
- Bavarian Nordic
- SIGA Technologies
- Arbutus Biopharma
- DynPort Vaccine
- Xoma Corporation
- Ichor Medical Systems
- Aeolus Pharmaceuticals
- Achaogen
- Elusys Therapeutics
- Dynavax Technologies
- Cleveland BioLabs
- Soligenix
- Alnylam Pharmaceuticals
Global Biodefense Market By Regions:
- North America
- Europe
- China
- Japan
- India
- Southeast Asia
- Other regions (Central & South America, Middle East & Africa)
Global Biodefense Market By Regions:
- North America
- United States
- Canada
- Mexico
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Singapore
- Rest of Asia-Pacific
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Russia
- Rest of Europe
- Central & South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- Turkey
- Rest of Middle East & Africa
Global Biodefense Market By Product:
- Anthrax
- Smallpox
- Botulism
- Radiation/Nuclear
- Others
Global Biodefense Market By Application:
- US Military Market
- US Civilian Market
- Non - US Market
The study objectives of this report are:
- To analyze and study the global Biodefense capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
- Focuses on the key Biodefense manufacturers, to study the capacity, production, value, market share and development plans in future.
- Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
- To define, describe and forecast the market by type, application and region.
- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
- To identify significant trends and factors driving or inhibiting the market growth.
- To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
- To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Biodefense are as follows:
- History Year: 2013-2017
- Base Year: 2017
- Estimated Year: 2018
- Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
- Key Stakeholders
- Biodefense Manufacturers
- Biodefense Distributors/Traders/Wholesalers
- Biodefense Subcomponent Manufacturers
- Industry Association
- Downstream Vendors
Available Customizations
- With the given market data, we offers customizations according to the company's specific needs. The following customization options are available for the report:
- Regional and country-level analysis of the Biodefense market, by end-use.
- Detailed analysis and profiles of additional market players.
Get the Complete Report & TOC @ https://www.24marketreports.com/life-sciences/global-biodefense-2018-524